NCT01304238View on ClinicalTrials.gov

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

CompletedOBSERVATIONAL
Enrollment

195

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Acute HIT II (Heparin-induced Thrombocytopenia Type II)
Interventions
DRUG

lepirudin

lepirudin

DRUG

danaparoid

danaparoid

DRUG

argatroban

argatroban

DRUG

fondaparinux

fondaparinux

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01304238 - Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II | Biotech Hunter | Biotech Hunter